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Abstract It is widely held that solid cell nests (SCN) of the
thyroid are ultimobranchial body remnants. SCNs are
composed of main cells and C cells. It has been suggested
that main cells might be pluripotent cells contributing to the
histogenesis of C cells and follicular cells, as well as to the
formation of certain thyroid tumors. The present study
sought to analyze the immunohistochemical profile of SCN
and to investigate the potential stem cell role of SCN main
cells. Tissue sections from ten cases of nodular hyperplasia
(non-tumor goiter) with SCNs were retrieved from the files
of the Hospital Infanta Luisa (Seville, Spain). Parathormone
(PTH), calcitonin (CT), thyroglobulin (TG), thyroid tran-
scription factor (TTF-1), galectin 3 (GAL3), cytokeratin 19
(CK 19), p63, bcl-2, OCT4, and SALL4 expression were
evaluated by immunohistochemistry. Patient clinical data
were collected, and tissue sections were stained with
hematoxylin–eosin for histological examination. Most cells
stained negative for PTH, CT, TG, and TTF-1. Some cells
staining positive for TTF-1 and CT required discussion.
However, bcl-2, p63, GAL3, and CK 19 protein expression
was detected in main cells. OCT4 protein expression was
detected in only two cases, and SALL4 expression in none.
Positive staining for bcl-2 and p63, and negative staining
for PTH, CT, and TG in SCN main cells are both consistent
with the widely accepted minimalist definition of stem
cells, thus supporting the hypothesis that they may play a
stem cell role in the thyroid gland, although further research
will be required into stem cell markers. Furthermore, p63
and GAL-3 staining provides a much more sensitive means
of detecting SCNs than staining for carcinoembryonic
antigen, calcitonin, or other markers; this may help to
distinguish SCNs from their mimics.
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Introduction
Solid cell nests (SCNs) of the thyroid have fascinated
pathologists since they were first described by Getzowa [1]
in 1907. Although it is now widely accepted that SCNs and
so-called “mixed” follicles are indeed ultimobranchial body
remnants [2–8], their biological significance remains
controversial [2–4, 9, 10]. It has been suggested that these
embryonic remnants may be the origin of certain ectopic
structures rarely reported in thyroid glands [3, 6] and also
of certain types of thyroid tumor [9, 10]. Moreover, SCNs
may be a source of confusion in thyroid pathology, as they
can mimic a number of pathological disorders [2, 3].
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SCNs are believed to harbor pluripotent stem cells [2, 3, 7].
Solid cell nests are composed of two cell types: “main cells”
and “Cc e l l s ” [3]. Main cells, which account for a major
proportion of SCNs, are polygonal-to-elongated cells with
centrally located, oval nuclei; they have uneven nuclear
envelopes and occasionally display strongly eosinophilic
cytoplasm with squamoid features (including high molecular
weight cytokeratins) but lack intercellular bridges [3]. The
minority C cells are characterized by clear cytoplasm and
small, compact, centrally located nuclei [2–4]. In up to 81%
of cases, mixed follicles may be found admixed with bona
fide SCNs [2–4]; these are composed of cells resembling
main cells and differentiated follicular cells arranged in a
follicular lumen-like pattern.
It has been suggested that main cells might be pluripotent
cells contributing to the histogenesis of C cells and follicular
cells [10], as well as to some thyroid tumors [11, 12], but
little research has addressed this hypothesis. If this were the
case, main cells might be expected to display a stem cell
phenotype, with the capacity both to self-renew and to
generate differentiated progeny, as well as the ability to exist
in a mitotically quiescent form, although these properties are
not always present in all human tissue stem cells [13].
The present study sought to analyze and characterize
thyroid differentiation markers (p63, bcl-2, cytokeratin 19,
galectin-3, TTF-1, thyroglobulin, calcitonin) and also stem
cell markers (OCT4 and SALL4) in SCNs found in nodular
hyperplasia.
Material and Methods
Formalin-fixed paraffin-embedded tissue sections from ten
SCN-containing surgical specimens obtained during total
thyroidectomy were retrieved from the files of the Hospital
Infanta Luisa (Seville, Spain). Sections were stained with
hematoxylin/eosin and evaluated by two pathologists.
Patient age, sex, functional status, and underlying SCN-
associated thyroid disease are summarized in Table 1. The
study was approved by the Hospital Ethical Committee and
informed consent was obtained from all participants.
For immunohistochemical analysis, 4 μm serial sections
were stained with a panel of antibodies (Table 2) using the
streptavidin–biotin–peroxidase complex technique. Negative
(primary antibody replaced by non-immune mouse serum)
and positive controls were included in each slide run. All
controls gave satisfactory results. A minimum of 10%
positive staining was adopted as a cut-off for all markers.
For p63 and TTF-1, only nuclear staining was considered
specific, while for other markers, only cytoplasmic staining
was accepted. Staining for GAL-3 was deemed positive
when observed in both nucleus and cytoplasm. Positive
nuclear and cytoplasmic staining for OCT4 and SALL4 was
evaluated.
Table 1 Summary of the patient's clinicopathological features and immunostaining findings in solid cell nests
Case A/S T3,T 4,
TSH
PD Main cells C cells
p63 bcl-2 CK19 GAL-3 TG TTF-1* CT p63 bcl-2 CK19 GAL-3 TG TTF-1 CT
1 64/F WNL NH + + + + −− −−− -+ − ++
2 45/M WNL NH + + + + −− −−− − + − ++
3 43/F WNL NH + + + + −− −−− − + − ++
4 36/F WNL NH + + + + −− −−− − + − ++
5 70/F WNL NH + + + + −− −−− − + − ++
6 37/F WNL NH + + + + −− −−− − + − ++
7 44/M WNL NH + + + + −− −−− − + − ++
8 69/F WNL NH + + + + −− −−− − + − ++
9 62/F WNL NH + + + + −− −−− − + − ++
10 46/F WNL NH + + + + −− −−− − + − ++
WNL within normal limits, PD pathological diagnosis, A age (years)/S sex (F female, M male), * 30 % of main cells shown positive
immunoreactions, CK 19 cytokeratin 19, GAL-3 galectin-3, TTF-1 thyroid transcription factor, TG thyroglobulin, CT calcitonin
Table 2 Antibodies used for immunohistochemical analysis
Antigen Antibody Dilution
Calcitonin Polyclonal (BioGenex, San Ramon CA) 1:5,000
TTF-1 8G7G3/1 (Dako, Glustrup, Denmark) 1:2,000
Thyroglobulin DAK-Tg6 (Dako, Glustrup, Denmark) 1:2,000
CK 19 RCK108 (Dako, Glustrup, Denmark) 1:100
P63 4A4 (Dako, Glustrup, Denmark) 1:50
Bcl-2 124 (Dako, Glustrup, Denmark) 1:20
Galectin-3 9C4 (Dako, Glustrup, Denmark) 1:200
TTF-1 thyroid transcription factor-1, CK 19 cytokeratin 19
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All tissue sections contained SCNs which are composed of a
complex admixture of main cells and C cells, as previously
described (Fig. 1a). Main cells displayed frequent nuclear
grooving. Intermingled with main cells, and mainly confined
to the periphery of cell nests, C cells were numerically less
conspicuous and were characterized by clear or empty
cytoplasm and round nuclei. In six cases (60%), solid cell
nests contained mixed follicles—structures lined by main
cells and follicular epithelium with colloid and/or clumps of
eosinophilic material in the lumen (Fig. 1b).
Positive staining for P63 was restricted to SCN main
cells (Fig. 2a). On all sections, C cells stained negative for
p63. No positive staining for p63 was observed in adjacent
thyroid tissue. Main cells in all tissue sections displayed
strong nuclear staining for bcl-2, while staining was
negative in C cells (Fig. 2b). Positive staining for CK19
was observed consistently in main cells, as well in follicular
cells of mixed and some adjacent follicles (Fig. 2c). In all
tissue sections, both main cells and C cells showed strong
nuclear and cytoplasmic staining for GAL-3 (Fig. 2d). No
positive staining for GAL-3 was detected in adjacent
thyroid tissue.
TG is considered the most specific marker of thyroid
follicular differentiation. Here, none of the SCNs stained
positive for TG (Fig. 2e). Conversely, thyroid follicular
cells and colloid were strongly positive for TG. CT staining
was detected in C cells of all SCNs and in parafollicular
cells of adjacent thyroid tissue (Fig. 2g). Positive staining
for TTF-1 was detected in all differentiated cells of the
thyroid parenchyma and in a few SCN cells, mainly those
forming mixed follicles (Fig. 2h). Positive staining for PTH
was not detected either in SCNs or in surrounding thyroid
tissue (Fig. 2f). Immunohistochemical findings and clinical
data are summarized in Table 1.
Only two cases showed granular cytoplasmic staining to
be negative in all cases for SALL4.
Discussion
Solid cell nests may pose a challenge to the thyroid
specialist, since they may be confused with squamous
metaplasia, metastatic squamous carcinoma, papillary
microcarcinoma, medullary carcinoma, and C cell hyper-
Fig. 1 Solid cell nests of the human thyroid. a. Solid cell nest
composed of a complex admixture of main and C-cell (X 20). b.
Cystic SCNs. Mixed follicles composed of cells resembling SCN main
cells and cuboidal cells arranged in a follicle-like structure (H/E, ×40)
Fig. 2 Immunohistochemical analysis. a. p63, strong nuclear staining
in main cells (×40). b. bcl-2, strong cytoplasmic staining in main cells
(×40).c. CK19, moderate cytoplasmic staining in main cells (×40). d.
GAL-3, strong cytoplasmic, and nuclear staining. Positive staining in
both main and C cells. e, f TG and PTH, negative staining in both
main and C cells (×40). g CT, moderate cytoplasmic staining in C
cells (×20). h TTF-1, moderate nuclear staining in a small number of
SCN cells, mainly those forming mixed follicles (×40)
Endocr Pathol (2011) 22:35–39 37plasia C [2, 3]. It has been assumed that a histological
evaluation based on the “typical” immunohistochemical
profile of SCNs (CEA and cytokeratins) should be
sufficient to distinguish them from their mimics [2, 3].
However, since CEA and cytokeratins are also coexpressed
in some neuroendocrine carcinomas [10, 14], other more
specific markers are required.
As reported by other authors [15], expression of GAL-3 in
the present study was sufficiently restricted to SCNs.
Moreover, positive staining for p63 was detected in SCN
main cells but not in surrounding thyroid tissue. Other
authors report similar findings [11, 12, 16], adding that p63
is not expressed in certain differentiated carcinomas (medul-
lary and follicular) [12, 17] and indeed is only exceptionally
expressed in foci of squamous metaplasia in papillary
carcinomas [18]. Thus, p63 may prove a highly effective
marker for distinguishing SCNs from other pathologies.
Although there is no precise definition of stem cells, it is
generally understood that they exhibit the capacity both to
self-renew and to generate differentiated progeny, as well as
the ability to exist in a mitotically quiescent form, although
these properties are not always present in all human tissue
stem cells [13].
P63 is a structural homolog belonging to the p53 tumor
suppressor family involved in the survival and differentia-
tion of stem cells in various epithelia [19, 20]. It has been
suggested that p63 may trigger the differentiation of certain
specific cell lines [19–21]. In addition, strong bcl-2
expression was detected here in main cells; this is
characteristic of a non-committed embryonic phenotype
associated with stem cells [22].
Main cells stained negative for two differentiation
markers, PTH and TG; this allowed SCNs to be distin-
guished from parathyroid tissue remnants and suggested the
absence of main cell differentiation towards TG-producing
follicular cells. However, positive staining for CT was
occasionally detected in SCN cells which resembled
parafollicular cells in surrounding thyroid tissue, suggesting
an intra-SCN differentation of this cell line. Positive
staining for TTF-1 was detected in some peripheral SCN
cells; to judge by the findings of other authors, these were
probably C cells [21]. Positive TTF-1 staining was also
noted in mixed follicle cells and in all follicles in
surrounding thyroid tissue. The hypothesis regarding the
embryonic nature of SCNs is borne out by the fact that
TTF-1—an early marker of thyroid cell differentiation
[23, 24]—was not expressed by most SCN cells (undiffer-
entiated cells). The putative stem cell role of SCNs is
further supported by the continuity observed between main
cells, mixed follicles, and follicular and parafollicular cells.
This strongly suggests that, as reported by other authors,
SCN main cells may be pluripotent cells contributing to the
histogenesis of C cells and follicular cells as well as to
some thyroid tumors [10]. This hypothesis is borne out by
the immunohistochemical profile of SCNs obtained in the
present study and by the findings of other authors who
report a marked capacity for self-renewal (telomerase
activity) a and low proliferation index in these cells [11].
U n t i ln o w ,S C N sh a v eb e e ns e e ns o l e l ya sam o r p h o l o g i c a l
featureof thyroidtissue;anumber of hypotheseshavebeenput
forwardregardingtheirnatureandtheirpurpose.The results of
the present study using stem cell markers failed to confirm the
initial hypothesis, since OCT4 protein expression—whose
significance is uncertain—was detected in only two cases, and
SALL4 expression in none. Future research should thus focus
on other specific stem cell markers (e.g., NANOG, SOX2).
As part of the general quest to identify specific stem cell
populationsinarangeoforgansandtissuesinbothhealthyand
sick patients [25, 26], a number of authors have postulated a
stem cell role for SCNs in the thyroid gland [10]; some
studies have even linked them to the genesis of several
tumors, including papillary, mucoepidermoid, and squamous
carcinoma [10, 11, 27]. Attempts have also been made to
demonstrate the presence the same BRAF mutation (V600E)
in SCNs and in micropapillary carcinoma [16]. There appears
to be no evidence to support the link between SCNs and
medullary carcinoma posited by a several authors [4, 28].
The literature, accordingly, contains contradictory views on
the potential link between stem cells, SCNs ad thyroid
carcinoma; however, all these views are based on immunohis-
tochemical profiles which fail to include absolutely specific
stem cell markers [29, 30]. The present results contribute to a
better knowledge of the nature of SCNs and may help clarify
the genesis of thyroid tumors; however, they provide no
indication of potential therapeutic strategies other than
surgery, which for the time being remains the only option.
Further research is required to determine the relationship
between main cells and certain thyroid carcinomas, partic-
ularly papillary thyroid carcinoma, whose cells—like SCN
cells—display strong positive staining for CK 19.
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